Junlebao Strategically Invested in Probiotics Enterprise “Yiran Biology”

Yiran Biology secured a strategic investment from Junlebao Dairy Group, achieving a powerful collaboration between a leading probiotics company and a dairy industry giant. Both parties will engage in comprehensive cooperation based on microbial research innovation and industrial deployment, promoting the high-quality development of independent intellectual property in microbial research and industry in China. Established in 2011, Yiran Biology is a high-tech enterprise focused on probiotic functional research, biomedical technology innovation, and industrialization. According to its official website, the company has an annual production capacity of 500 tons of pure bacterial powder and 3,000 tons of fermentation liquid, with applications spanning food processing, preventive healthcare, livestock farming, and agriculture. (Source: FoodTalks)

Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE

Visit HPA-China’s Information Hub, HERE